Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK)
HKD 9.47
(1.5%)
HKD 9.47
(1.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 511.71 Million | 41 Million | 164.78 Million | 260.68 Million | 231.54 Million | 108.5 Million |
| Net Income | 277.81 Million | 307.71 Million | 322.36 Million | 283.37 Million | 236.76 Million | 105.64 Million |
| Depreciation & Amortization | 34.65 Million | 30.03 Million | 18.3 Million | 14.94 Million | 11.79 Million | 7.41 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 195.75 Million | -295.86 Million | -196.15 Million | -43.21 Million | -27.12 Million | -4.99 Million |
| Other non-cash items | 90.1 Thousand | -878.77 Thousand | 20.27 Million | 5.58 Million | 10.1 Million | 438.55 Thousand |
| Investing Cash Flow | -81.55 Million | -762.61 Million | -190.34 Million | -21.53 Million | -125.5 Million | -48.21 Million |
| Investments in PPE | -33.24 Million | -24.9 Million | -199.4 Million | -24 Million | -132.41 Million | -52.11 Million |
| Acquisitions | -6.98 Million | 0.66 | - | - | - | - |
| Investment purchases | -2.4 Billion | -2.17 Billion | - | - | - | - |
| Sales/Maturities of investments | 2.36 Billion | 1.42 Billion | - | - | - | - |
| Other Investing Activities | -41.32 Million | 13.78 Million | 9.06 Million | 2.46 Million | 6.9 Million | 3.9 Million |
| Financing Cash Flow | -121.33 Million | -59.03 Million | 1.07 Billion | -11.87 Million | -56.81 Million | -15.97 Million |
| Debt repayment | -1.27 Million | -1.93 Million | -2.19 Million | - | - | - |
| Dividends payments | -120.05 Million | -49.95 Million | - | -11.87 Million | -56.81 Million | -15.97 Million |
| Common Stock Repurchased | - | -7.14 Million | - | - | - | - |
| Common Stock Issuance | - | 9.07 Million | - | - | - | - |
| Other Financing Activities | -1.27 Million | -9.07 Million | 1.07 Billion | - | - | - |
| Accounts receivables | 294.85 Million | -412.16 Million | -225.07 Million | -112.45 Million | -136.93 Million | -52.41 Million |
| Accounts payables | - | 412.16 Million | 225.07 Million | 112.45 Million | 136.93 Million | - |
| Inventory | -193.3 Million | -113.56 Million | -1.57 Million | 22.6 Million | -104.39 Million | -38.37 Million |
| Other working capital | 94.2 Million | -182.3 Million | -194.57 Million | -65.82 Million | 77.27 Million | 33.38 Million |
| Cash at beginning of period | 957.19 Million | 1.73 Billion | 690.11 Million | 464.17 Million | 414.91 Million | 371.61 Million |
| Cash at end of period | 1.26 Billion | 957.19 Million | 1.73 Billion | 690.11 Million | 464.17 Million | 414.91 Million |
| Capital Expenditure | -33.24 Million | -24.9 Million | -199.4 Million | -24 Million | -132.41 Million | -52.11 Million |
| Effect of forex changes on cash | -4213.37 | 1.33 Million | -1.72 Million | -1.33 Million | 38.91 Thousand | -1.02 Million |
| Net cash flow / Change in cash | 308.81 Million | -779.3 Million | 1.04 Billion | 225.93 Million | 49.26 Million | 43.29 Million |
| Free Cash Flow | 478.47 Million | 16.1 Million | -34.62 Million | 236.67 Million | 99.12 Million | 56.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 23.91 Million | 55.1 Million | 97.2 Million | 277.81 Million | 54.54 Million | 70.21 Million |
| Depreciation & Amortization | 18.65 Million | - | 34.05 Million | 34.65 Million | -15.84 Million | 15.84 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -79.34 Million | - | 101.54 Million | 195.75 Million | 104.25 Million | -104.25 Million |
| Other non-cash items | 97.32 Million | -184.72 Million | 265.16 Million | 90.1 Thousand | -90.23 Million | 99.41 Million |
| Investing Cash Flow | -4.09 Million | 83.72 Million | -21.79 Thousand | -81.55 Million | -17.59 Million | -65.48 Million |
| Investments in PPE | -8.34 Million | -13.5 Million | 1.35 Million | -33.24 Million | -15.45 Million | -18.11 Million |
| Acquisitions | - | - | - | -6.98 Million | -3.3 Million | 5.91 Million |
| Investment purchases | - | - | - | -2.4 Billion | 0.34 | - |
| Sales/Maturities of investments | - | - | - | 2.36 Billion | -12.59 Million | - |
| Other Investing Activities | 4.24 Million | 97.22 Million | -1.37 Million | -41.32 Million | 13.75 Million | -53.28 Million |
| Financing Cash Flow | -554.4 Thousand | - | -554.4 Thousand | -121.33 Million | 120.91 Million | 70.19 Thousand |
| Debt repayment | - | - | - | -1.27 Million | - | - |
| Dividends payments | - | - | - | -120.05 Million | -120.05 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -554.4 Thousand | - | -554.4 Thousand | -1.27 Million | 240.96 Million | 70.19 Thousand |
| Accounts receivables | 11.79 Million | - | 294.85 Million | 294.85 Million | -24.42 Million | 24.42 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -91.14 Million | - | -193.3 Million | -193.3 Million | 128.67 Million | -128.67 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.22 Billion | 1.26 Billion | 769.3 Million | 957.19 Million | 854.82 Million | 838.34 Million |
| Cash at end of period | 1.27 Billion | 1.22 Billion | 1.26 Billion | 1.26 Billion | 769.3 Million | 854.82 Million |
| Capital Expenditure | -8.34 Million | -13.5 Million | 1.35 Million | -33.24 Million | -15.45 Million | -18.11 Million |
| Effect of forex changes on cash | 1.28 Million | -4213.00 | -677.77 Thousand | -4213.37 | -241.55 Million | 673.55 Thousand |
| Net cash flow / Change in cash | 57.19 Million | -45.88 Million | 496.71 Million | 308.81 Million | -85.52 Million | 16.48 Million |
| Free Cash Flow | 52.21 Million | -143.11 Million | 499.32 Million | 478.47 Million | 37.26 Million | 63.11 Million |
HYT
605117
9919
ALAR
ZOTA
NVVE